A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1.

@article{Linsky2011ACF,
  title={A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1.},
  author={Thomas W. Linsky and Walter Fast},
  journal={Journal of biomolecular screening},
  year={2011},
  volume={16 9},
  pages={1089-97}
}
Inhibitors of human dimethylarginine dimethylaminohydrolase-1 (DDAH-1) are of therapeutic interest for controlling pathological nitric oxide production. Only a limited number of biologically useful inhibitors have been identified, so structurally diverse lead compounds are desired. In contrast with previous assays that do not possess adequate sensitivity for optimal screening, herein is reported a high-throughput assay that uses an alternative thiol-releasing substrate, S-methyl-L… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Fast, W. high throughput screening for dimethylarginine dimethylaminohydrolase inhibitors to Control nitric oxide reveals ebselen as a Bioavailable Covalent inactivator

t. W. linsky, y. Wang
J. Med. Chem. Lett. articles asaP, June • 2011

nandi, m. the therapeutic Potential of targeting endogenous inhibitors of nitric oxide synthesis

J. leiper
Nat. Rev. Drug Discov. 2011, • 2011

Similar Papers

Loading similar papers…